Patent · US Active

Risk calculation for evaluation of fetal aneuploidy

US10718019B2 · kind B2 · utility

1Cited by
124References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 2015
Grant dateJul 21, 2020
Priority date
Expiry dateSep 16, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

The present invention provides processes for determining accurate risk probabilities for fetal aneuploidies. Specifically, the invention provides non-invasive evaluation of genomic variations through chromosome-selective sequencing and non-host fraction data analysis of maternal samples.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.